Citigroup Inc Acadia Pharmaceuticals Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Citigroup Inc holds 120,127 shares of ACAD stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

120,127

Previous 66,840 79.72%

Holding current value

$2.05 Million

Previous $1.09 Million 70.17%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$15.14 - $19.14 $806,765 - $1.02 Million	53,287 Added 79.72%	120,127 $1.85 Million
Q2 2024 Aug 12, 2024	SELL	$14.62 - $18.42 $4.2 Million - $5.29 Million	-287,063 Reduced 81.11%	66,840 $1.09 Million
Q1 2024 May 10, 2024	BUY	$17.79 - $30.86 $2.33 Million - $4.05 Million	131,185 Added 58.9%	353,903 $6.54 Million
Q4 2023 Feb 09, 2024	BUY	$20.78 - $31.77 $1.58 Million - $2.41 Million	75,854 Added 51.65%	222,718 $6.97 Million
Q3 2023 Nov 09, 2023	BUY	$20.84 - $33.47 $58,060 - $93,247	2,786 Added 1.93%	146,864 $3.06 Million
Q2 2023 Aug 10, 2023	SELL	$17.8 - $25.65 $2.39 Million - $3.45 Million	-134,450 Reduced 48.27%	144,078 $3.45 Million
Q1 2023 May 11, 2023	BUY	$16.32 - $20.92 $386,620 - $495,594	23,690 Added 9.3%	278,528 $5.24 Million
Q4 2022 Feb 09, 2023	SELL	$14.2 - $18.63 $1.76 Million - $2.31 Million	-123,892 Reduced 32.71%	254,838 $4.06 Million
Q3 2022 Nov 10, 2022	BUY	$14.11 - $18.27 $1.61 Million - $2.09 Million	114,242 Added 43.19%	378,730 $6.2 Million
Q2 2022 Aug 10, 2022	BUY	$13.01 - $27.22 $2.82 Million - $5.91 Million	216,941 Added 456.27%	264,488 $3.73 Million
Q1 2022 May 12, 2022	SELL	$20.94 - $27.5 $3.63 Million - $4.76 Million	-173,146 Reduced 78.46%	47,547 $1.15 Million
Q4 2021 Feb 10, 2022	SELL	$16.79 - $27.09 $98,792 - $159,397	-5,884 Reduced 2.6%	220,693 $5.15 Million
Q3 2021 Nov 10, 2021	BUY	$15.78 - $24.77 $3.58 Million - $5.61 Million	226,577 New	226,577 $3.76 Million

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account